Co-transduction of ribosomal protein L23 enhances the therapeutic efficacy of adenoviral-mediated p53 gene transfer in human gastric cancer

Oncology Reports

Volumn 30, Issue 4, 2013, Pages 1989-1995

  Zhang, Ya Fei ^a,b   Zhang, Bi Cheng ^a   Zhang, An Ran ^b   Wu, Ting Ting ^a   Liu, Jian ^a   Yu, Li Fang ^a   Wang, Wei Xing ^a   Gao, Jian Fei ^a   Fang, Dian Chun ^b   Rao, Zhi Guo ^a  

^a WUHAN GENERAL HOSPITAL OF GUANGZHOU COMMAND   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Gastric cancer; Gene therapy; Murine double minute 2; P53; Ribosomal protein L23

Indexed keywords

ADENOVIRUS VECTOR; PROTEIN MDM2; PROTEIN P53; RIBOSOMAL PROTEIN L23; RIBOSOME PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BICISTRON; CANCER CELL; CANCER GENE THERAPY; CANCER INHIBITION; CELL DEATH; CISTRON; CONTROLLED STUDY; DRUG EFFICACY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; STOMACH CANCER; SURVIVAL TIME; VIRAL GENE THERAPY;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CYCLIN-DEPENDENT KINASE INHIBITOR P21; GENETIC THERAPY; GENETIC VECTORS; HETEROGRAFTS; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; MITOCHONDRIAL PROTEINS; NEOPLASM TRANSPLANTATION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; RIBOSOMAL PROTEINS; STOMACH NEOPLASMS; TRANSDUCTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84882591973     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2663     Document Type: Article

References (30)

1. Cheok CF, Verma CS, Baselga J and Lane DP: Translating p53 into the clinic. Nat Rev Clin Oncol 8: 25-37, 2011.
2. Brown CJ, Lain S, Verma CS, Fersht AR and Lane DP: Awakening guardian angels: drugging the p53 pathway. Nat Rev Cancer 9: 862-873, 2009.
3. Lane DP and Lain S: Therapeutic exploitation of the p53 pathway. Trends Mol Med 8 (Suppl 4): S38-S42, 2002.
4. Lane DP, Cheok CF and Lain S: p53-based cancer therapy. Cold Spring Harb Perspect Biol 2: a001222, 2010.
5. Momand J, Zambetti GP, Olson DC, George D and Levine AJ: The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69: 1237-1245, 1992.
6. Haupt Y, Maya R, Kazaz A and Oren M: Mdm2 promotes the rapid degradation of p53. Nature 387: 296-299, 1997.
7. Kubbutat MH, Jones SN and Vousden KH: Regulation of p53 stability by Mdm2. Nature 387: 299-303, 1997.
8. Marine JC and Lozano G: Mdm2-mediated ubiquitylation: p53 and beyond. Cell Death Differ 17: 93-102, 2010.
9. Moll UM and Petrenko O: The MDM2-p53 interaction. Mol Cancer Res 1: 1001-1008, 2003.
10. Shangary S and Wang S: Targeting the MDM2-p53 interaction for cancer therapy. Clin Cancer Res 14: 5318-5324, 2008.
11. Wiman KG: Strategies for therapeutic targeting of the p53 pathway in cancer. Cell Death Differ 13: 921-926, 2006.
12. van Beusechem VW, van den Doel PB and Gerritsen WR: Conditionally replicative adenovirus expressing degradation-resistant p53 for enhanced oncolysis of human cancer cells overexpressing murine double minute 2. Mol Cancer Ther 4: 1013-1018, 2005.
13. Nishizaki M, Sasaki J, Fang B, Atkinson EN, Minna JD, Roth JA and Ji L: Synergistic tumor suppression by coexpression of FHIT and p53 coincides with FHIT-mediated MDM2 inactivation and p53 stabilization in human non-small cell lung cancer cells. Cancer Res 64: 5745-5752, 2004.
14. Dai MS, Zeng SX, Jin Y, Sun XX, David L and Lu H: Ribosomal protein L23 activates p53 by inhibiting MDM2 function in response to ribosomal perturbation but not to translation inhibition. Mol Cell Biol 24: 7654-7668, 2004.
15. Jin A, Itahana K, O'Keefe K and Zhang Y: Inhibition of HDM2 and activation of p53 by ribosomal protein L23. Mol Cell Biol 24: 7669-7680, 2004.
16. Zhang Y, Shi Y, Li X, et al: Inhibition of the p53-MDM2 interaction by adenovirus delivery of ribosomal protein L23 stabilizes p53 and induces cell cycle arrest and apoptosis in gastric cancer. J Gene Med 12: 147-156, 2010.
17. Ohashi M, Kanai F, Ueno H, et al: Adenovirus mediated p53 tumour suppressor gene therapy for human gastric cancer cells in vitro and in vivo. Gut 44: 366-371, 1999.
18. Jiang XH, Wong BC, Lin MC, et al: Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-κB activation in gastric cancer cells. Oncogene 20: 8009-8018, 2001.
19. Sun S, Li XM, Li XD and Yang WS: Studies on inducing apoptosis effects and mechanism of CIK cells for MGC-803 gastric cancer cell lines. Cancer Biother Radiopharm 20: 173-180, 2005.
20. Kim HJ, Cho HI, Han YH, et al: Efficient transduction with recombinant adenovirus in EBV-transformed B lymphoblastoid cell lines. J Biochem Mol Biol 37: 376-382, 2004.
21. Yang HY, Zhang WG, Ma LP, Wang SW and Zhang ZY: An approach to enhancing the phototoxicity of a novel hypocrellin congener to MGC803 cells. Dyes Pigments 51: 103-110, 2001.
22. Furukawa T, Kubota T, Watanabe M, Kitajima M and Hoffman RM: Orthotopic transplantation of histologically intact clinical specimens of stomach cancer to nude mice: correlation of metastatic sites in mouse and individual patient donors. Int J Cancer 53: 608-612, 1993.
23. Shi J, Wei PK, Zhang S, et al: OB glue paste technique for establishing nude mouse human gastric cancer orthotopic transplantation models. World J Gastroenterol 14: 4800-4804, 2008.
24. Ozaki T and Nakagawara A: p53: the attractive tumor suppressor in the cancer research field. J Biomed Biotechnol 2011: 603925, 2011.
25. Amaral JD, Xavier JM, Steer CJ and Rodrigues CM: Targeting the p53 pathway of apoptosis. Curr Pharm Des 16: 2493-2503, 2010.
26. Levine AJ: p53, the cellular gatekeeper for growth and division. Cell 88: 323-331, 1997.
27. Tisato V, Norcio A, Voltan R, Celeghini C, Zella D and Secchiero P: MDM2 non-genotoxic inhibitors as innovative therapeutic approaches for the treatment of pediatric malignancies. Curr Med Chem 20: 2226-2236, 2013.
28. Graat HC, Carette JE, Schagen FH, et al: Enhanced tumor cell kill by combined treatment with a small-molecule antagonist of mouse double minute 2 and adenoviruses encoding p53. Mol Cancer Ther 6: 1552-1561, 2007.
29. Tango Y, Fujiwara T, Itoshima T, et al: Adenovirus-mediated p14ARF gene transfer cooperates with Ad5CMV-p53 to induce apoptosis in human cancer cells. Hum Gene Ther 13: 1373-1382, 2002.
30. Huang Y, Tyler T, Saadatmandi N, Borgstrom P and Gjerset RA: Enhanced tumor suppression by a p14ARF/p53 bicistronic adenovirus through increased p53 protein translation and stability. Cancer Res 63: 3646-3653, 2003.